Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1957 Dec;12(4):438–446. doi: 10.1111/j.1476-5381.1957.tb00162.x

Protection against the lethal effects of organophosphates by pyridine-2-aldoxime methiodide

F Hobbiger
PMCID: PMC1510585  PMID: 13489171

Abstract

The mechanism responsible for the protection against lethal organophosphate poisoning by pyridine-2-aldoxime methiodide (P-2-AM) was studied in the mouse. Two types of organophosphates were used: ethyl pyrophosphate (TEPP), E 600, Ro 3-0340, and Ro 3-0422 which form with true cholinesterase a diethylphosphoryl enzyme (1) and DFP, D 600, and Ro 3-0351 which form with true cholinesterase a diisopropylphosphoryl enzyme (2).

In vitro and under the experimental conditions used more than 50% reactivation of (1) was obtained within 1 hr. by concentrations of P-2-AM ranging from 0.5 to 1×10-5 M; 30 times higher concentrations of the oxime were required to achieve the same effect with (2). In vivo reactivation of phosphorylated true cholinesterases in blood amounted to 10 to 24% within the first 30 min. if 25 mg./kg. P-2-AM was injected (i.p.) 5 min. before a sublethal dose of TEPP, E 600, Ro 3-0340, or Ro 3-0422 and reactivation reached a maximum within 1 to 2 hr. after the injection of the oxime. P-2-AM was more effective when given 30 min. after the organophosphate. The effect of 25 mg./kg. P-2-AM on the phosphorylated true cholinesterase in brain (experiments with TEPP and E 600) was negligible. A dose of 25 mg./kg. P-2-AM had no consistent effect on the phosphorylated true cholinesterases in blood and brain of mice injected with sublethal doses of DFP, D 600, or Ro 3-0351.

The protection by 25 mg./kg. P-2-AM against lethal doses of TEPP, E 600, Ro 3-0422, and Ro 3-0340 was greater than that obtained with 50 mg./kg. atropine sulphate, but the degree of protection was determined by the organophosphate itself and not its dialkylphosphoryl group. Protection by 25 mg./kg. P-2-AM against lethal doses of DFP, D 600, and Ro 3-0351 was negligible. The antidotal effect of P-2-AM was potentiated by atropine. Mice which were injected with atropine and P-2-AM were protected to a greater extent against DFP than against Ro 3-0422, and protection against DFP was only slightly less than protection against TEPP. This is difficult to reconcile with a specific action of P-2-AM on phosphorylated cholinesterases.

Full text

PDF
438

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALDRIDGE W. N., DAVISON A. N. The mechanism of inhibition of cholinesterases by organophosphorus compounds. Biochem J. 1953 Dec;55(5):763–766. doi: 10.1042/bj0550763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ASKEW B. M., DAVIES D. R., GREEN A. L., HOLMES R. The nature of the toxicity of 2-oxo-oximes. Br J Pharmacol Chemother. 1956 Dec;11(4):424–427. doi: 10.1111/j.1476-5381.1956.tb00010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ASKEW B. M. Oximes and hydroxamic acids as antidotes in anticholinesterase poisoning. Br J Pharmacol Chemother. 1956 Dec;11(4):417–423. doi: 10.1111/j.1476-5381.1956.tb00009.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BURGEN A. S. V., HOBBIGER F. The inhibition of cholinesterases by alkyl-phosphates and alkylphenolphosphates. Br J Pharmacol Chemother. 1951 Dec;6(4):593–605. doi: 10.1111/j.1476-5381.1951.tb00670.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CHILDS A. F., DAVIES D. R., GREEN A. L., RUTLAND J. P. The reactivation by oximes and hydroxamic acids of cholinesterase inhibited by organo-phosphorus compounds. Br J Pharmacol Chemother. 1955 Dec;10(4):462–465. doi: 10.1111/j.1476-5381.1955.tb00106.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. COHEN J. A., POSTHUMUS C. H. The mechanism of action of anti-cholinesterases. Acta Physiol Pharmacol Neerl. 1955;4(1):17–36. [PubMed] [Google Scholar]
  7. DAVIES D. R., GREEN A. L. The kinetics of reactivation, by oximes, of cholinesterase inhibited by organophosphorus compounds. Biochem J. 1956 Aug;63(4):529–535. doi: 10.1042/bj0630529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DE CANDOLE C. A., DOUGLAS W. W., EVANS C. L., HOLMES R., SPENCER K. E., TORRANCE R. W., WILSON K. M. The failure of respiration in death by anticholinesterase poisoning. Br J Pharmacol Chemother. 1953 Dec;8(4):466–475. doi: 10.1111/j.1476-5381.1953.tb01350.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DE CANDOLE C. A., McPHAIL M. K. Pentamethonium as an adjuvant to atropine in the therapy of paraoxon poisoning. Nature. 1954 Sep 18;174(4429):552–553. doi: 10.1038/174552a0. [DOI] [PubMed] [Google Scholar]
  10. DOUGLAS W. W., PATON W. D. M. The mode of action of tetraethyl pyrophosphate at the cat's neuromuscular junction. J Physiol. 1951 Dec 28;115(4):71–P. [PubMed] [Google Scholar]
  11. DUBOIS K. P., DOULL J., OKINAKA A. J., COON J. M. Studies on the toxicity and pharmacological actions of symmetrical and unsymmetrical diethyl bis (dimethylamido) pyrophosphate. J Pharmacol Exp Ther. 1953 Apr;107(4):464–477. [PubMed] [Google Scholar]
  12. GROBLEWSKI G. E., MCNAMARA B. P., WILLS J. H. Stimulation of denervated muscle by DFP and related compounds. J Pharmacol Exp Ther. 1956 Sep;118(1):116–122. [PubMed] [Google Scholar]
  13. HOBBIGER F. The inhibition of cholinesterases by 3-(diethoxyphosphinyloxy)-N-methylquinolinium methylsulphate and its tertiary base. Br J Pharmacol Chemother. 1954 Jun;9(2):159–165. doi: 10.1111/j.1476-5381.1954.tb00835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. HOLMES R., ROBINS E. L. The reversal by oximes of neuromuscular block produced by anticholinesterases. Br J Pharmacol Chemother. 1955 Dec;10(4):490–495. doi: 10.1111/j.1476-5381.1955.tb00110.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. KEWITZ H. A specific antidote against lethal alkyl phosphate intoxication. III. Repair of chemical lesion. Arch Biochem Biophys. 1957 Feb;66(2):263–270. doi: 10.1016/s0003-9861(57)80001-0. [DOI] [PubMed] [Google Scholar]
  16. KEWITZ H., NACHMANSOHN D. A specific antidote against lethal alkyl phosphate intoxication. IV. Effects in brain. Arch Biochem Biophys. 1957 Feb;66(2):271–283. [PubMed] [Google Scholar]
  17. KEWITZ H., NACHMANSOHN D., WILSON I. B. A specific antidote against lethal alkyl phosphate intoxication. II. Antidotal properties. Arch Biochem Biophys. 1956 Oct;64(2):456–465. doi: 10.1016/0003-9861(56)90288-0. [DOI] [PubMed] [Google Scholar]
  18. KOELLE G. B., STEINER E. C. The cerebral distributions of a tertiary and a quaternary anticholinesterase agent following intravenous and intraventricular injection. J Pharmacol Exp Ther. 1956 Dec;118(4):420–434. [PubMed] [Google Scholar]
  19. LEWIS J. R., MCKEON W. B., Jr, LANDS A. M. Effect of various drugs in antagonizing the toxicity of TEPP. Arch Int Pharmacodyn Ther. 1955 Aug 1;102(4):371–390. [PubMed] [Google Scholar]
  20. MURTHA E. F., MCNAMARA B. P., EDBERG L. J., BERGNER A. D., WILLS J. H. Studies on the pharmacology of tetraethylpyrophosphate. J Pharmacol Exp Ther. 1955 Nov;115(3):291–299. [PubMed] [Google Scholar]
  21. PARKES M. W., SACRA P. Protection against the toxicity of cholinesterase inhibitors by acetylcholine antagonists. Br J Pharmacol Chemother. 1954 Sep;9(3):299–305. doi: 10.1111/j.1476-5381.1954.tb01685.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. STEWART W. C. Accumulation of acetylcholine in brain and blood of animals poisoned with cholinesterase inhibitors. Br J Pharmacol Chemother. 1952 Jun;7(2):270–276. doi: 10.1111/j.1476-5381.1952.tb01322.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. WILSON I. B., GINSBURG B. A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase. Biochim Biophys Acta. 1955 Sep;18(1):168–170. doi: 10.1016/0006-3002(55)90040-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES